Funding for this research was provided by:
Medical Research Council (MR/M015610/1)
Cancer Research UK (A16893)
Celgene (AX-CL-Panc-PI-003922)
Article History
Received: 16 December 2018
Accepted: 6 June 2019
First Online: 26 June 2019
Ethics approval and consent to participate
: Not applicable for the data in this manuscript.Ethical approval for STARPAC clinical trial; South Central - Berkshire Research Ethics Committee; 15/SC/0548 dated 13 October 2015.
: Not applicable.
: HMK received funding for Investigator Initiated trial from Celgene Sarl (AX-CL-Panc-PI-003922).